Effects of chronic airway inflammation on the activity and enzymatic inactivation of neuropeptides in guinea pig lungs

The Journal of Clinical Investigation
C M LillyJ M Drazen

Abstract

The effects of airway inflammation induced by chronic antigen exposure on substance P (SP)-induced increases and vasoactive intestinal peptide (VIP)-induced decreases in airway opening pressure (Pao), and the recovery of intact and hydrolyzed radiopeptide were studied in tracheally perfused guinea pig lungs. SP (10(-6) mol/kg) induced a significantly greater increase in Pao in lungs from antigen-exposed (30 +/- 5 cm H2O) than saline-exposed animals (15 +/- 1 cm H2O, P < 0.05). Significantly more intact 3H-SP and significantly less 3H-SP 1-7, a neutral endopeptidase (NEP) hydrolysis product, were recovered from the lung effluent of antigen-exposed than saline-exposed animals (P < 0.05). Injection of VIP (10(-9) mol/kg) induced significantly more pulmonary relaxation in saline-exposed compared with antigen-exposed lungs (62 +/- 4%, P < 0.001). In contrast to effluent from saline-exposed animals, lung effluent from antigen-exposed lungs contained less intact VIP, increased amounts of a tryptic hydrolysis product, and no products consistent with the degradation of VIP by NEP. These data indicate that inflamed lungs are more sensitive to the contractile effects of SP because it is less efficiently degraded by NEP and are less sensit...Continue Reading

References

Jan 10, 1993·The New England Journal of Medicine·E R McFadden, I A Gilbert
Jan 1, 1990·The Journal of Clinical Investigation·M A MartinsJ M Drazen
Jan 1, 1991·International Archives of Allergy and Applied Immunology·P J Barnes
Mar 1, 1991·The American Review of Respiratory Disease·J A Nadel, D B Borson
May 1, 1990·American Journal of Respiratory Cell and Molecular Biology·E K TamG H Caughey
Jun 1, 1987·The Journal of Clinical Investigation·N P Stimler-Gerard
Jun 19, 1987·European Journal of Pharmacology·S ManziniC Bacciarelli
Feb 1, 1988·The American Review of Respiratory Disease·J E Thompson, D Sheppard
Nov 30, 1989·The New England Journal of Medicine·P J Barnes
Jun 1, 1989·Chest·J A Nadel, G H Caughey
Jan 1, 1986·Advances in Enzyme Regulation·N KatunumaH Kido

❮ Previous
Next ❯

Citations

Oct 1, 1996·General Pharmacology·A Lindén
Apr 9, 1998·Peptides·S YoshiharaS Watanabe
Mar 1, 1995·The Journal of Experimental Medicine·M E RothenbergP Leder
Jan 28, 1998·American Journal of Respiratory and Critical Care Medicine·K J Haley, J M Drazen
Nov 17, 1998·American Journal of Respiratory and Critical Care Medicine·A J CohenY E Miller
Jun 12, 2010·American Journal of Respiratory Cell and Molecular Biology·Greet HensPeter W Hellings
Apr 12, 2011·Respiratory Research·Dongmei WuYong Kiel Sung
Sep 7, 2001·Environmental Health Perspectives·M J Carr, B J Undem
Jun 15, 2007·Proceedings of the National Academy of Sciences of the United States of America·Morris F TanskySusan E Leeman
Jul 9, 2010·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Tsu-Nai WangYing-Chin Ko
Feb 14, 2006·European Journal of Pharmacology·David A GronebergAxel Fischer
Sep 29, 1999·Pulmonary Pharmacology & Therapeutics·L Lindén
Oct 18, 2001·Pulmonary Pharmacology & Therapeutics·D A GronebergA Fischer
Oct 18, 2003·Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society·S RanganathanR Jaffe
Apr 15, 1999·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·V H van der Velden, A R Hulsmann
Mar 22, 2001·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·Q LiuM Yasui
May 1, 1996·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·Z DiamantP J Sterk
Nov 24, 1999·Allergy·B J UndemD D Hunter
Oct 18, 1996·The Journal of Biological Chemistry·D A BagarozziJ Travis
Oct 20, 2019·Biotechnology and Applied Biochemistry·Cristina BarciaPaula Veríssimo
Apr 14, 2010·Inhalation Toxicology·Simon S WongJefferey L Burgess
Feb 9, 2000·American Journal of Physiology. Cell Physiology·I Rubinstein
Feb 2, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Se-Woong OhWilliam R Henderson
Dec 14, 2001·American Journal of Physiology. Lung Cellular and Molecular Physiology·Brian MorseCraig M Lilly
Mar 17, 2004·Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society·Aly G SaadJerzy Stanek
Apr 20, 2004·The American Journal of the Medical Sciences·Thomas B Casale, Mark S Dykewicz

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.